DOI: 10.4244/EIJV7I3A50

Virtual bench testing of new generation coronary stents: why would we want to publish this paper?

Wim J. van der Giessen, MD, PhD; Frank Gijsen*, PhD; Hector M. Garcia-Garcia, MD, PhD; Patrick W. Serruys, MD, PhD, FESC

Editorial boards should take the interests of their primary readership into account when they choose contributions to be published in their journals. This is even more true for scientific journals which have a smaller audience and a more focused group of subscribers. This issue of EuroIntervention contains an article by Mortier et al1 that describes the virtual testing of coronary stent behaviour after implantation in a theoretical numerical arterial environment. Our readers may be puzzled what this type of research means for their daily clinical practice and while the editorial board of this journal understands –and to a certain extent shares this point of view– we nevertheless decided to expose our readership to this paper. Below we give a number of arguments that summarise our motives for publishing this article.

Interaction between different disciplines

It often arouses our attention when somebody from another discipline makes a statement or asks about what we do in our profession. Doctors suddenly see their profession through other eyes. Indeed, the reconstructions and resulting images Mortier and co-workers produce may provide us with a new mental image of what we do during clinical interventions. This could make us think differently about our daily practice, which may sometimes lead to new ideas. True innovations in medical areas are often born in those transition zones between different expertises.

It provides technical data that can be used for making better instruments

Forces measured in vitro can give an indication of the forces that operate on the various parts of the equipment; e.g., guide catheter, wires, stent. Of course, these virtual data have to be confirmed by in vivo measurements, but this type of work can improve the way the device industry produces instruments that can cause less damage and are more effective.

Virtual bench testing may replace some of (pre)clinical studies necessary to obtain regulatory approval

In the aircraft industry, virtual bench testing of materials is an integral part of the “reliable systems design” that dominates the design and testing of the airframe. A similar role for virtual bench testing in the design of endovascular devices can be envisioned. As a matter of fact, the FDA includes finite element simulations as a recommendation to be included in the test report for each stent design in its April 18, 2010 “Guidance for non-clinical engineering tests and recommended labelling for intravascular stents”.2 Studies like the one by Mortier and co-workers may provide the input to judge essential material and design requirements in a more advanced setting.

Virtual bench testing may become the standard for operator training

Flight simulators are a standard component of training aircraft pilots. In minimal invasive surgery, simulators are increasingly used for the initial familiarisation with equipment and procedures. It is conceivable that simulator training will become an integral part of medical training and testing as well. In addition, similar technological approaches provide data for haptic technology incorporated into simulation learning of cardiovascular interventions.

Finally, we may be all wrong...

Several important developments in medicine were initially overlooked, but also had their early “criticasters”. The position of our board is that interaction between engineers and doctors is important in our technology driven discipline. But only time will tell if we were right.

Conflict of interest statement

The authors have no conflict of interest to declare.

References

Volume 7 Number 3
Jul 29, 2011
Volume 7 Number 3
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-24-00010 Apr 15, 2024
Timing of revascularisation in acute coronary syndromes with multivessel disease – two sides of the same coin
Stähli B and Stehli J
free

Editorial

10.4244/EIJ-E-24-00016 Apr 15, 2024
Can artificial intelligence help Heart Teams make decisions?
Koch V
free

Editorial

10.4244/EIJ-E-24-00006 Apr 15, 2024
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Dauerman H and Lahoud R
free

State-of-the-Art

10.4244/EIJ-D-23-00836 Apr 15, 2024
Renal denervation in the management of hypertension
Lauder L et al
free

Research Correspondence

10.4244/EIJ-D-23-01046 Apr 15, 2024
Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock
Giustino G et al
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved